HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

SIHUAN PHARM

0.815

-0.055-6.32%

Volume:105.27M

Turnover:88.92M

Market Cap:7.44B

PE:35.47

High:0.895

Open:0.870

Low:0.810

Close:0.870

52wk High:1.896

52wk Low:0.810

Shares:9.13B

HK Float Shares:9.13B

Volume Ratio:3.15

T/O Rate:1.15%

Dividend:0.02

Dividend Rate:2.79%

EPS(LYR):0.023

ROE:3.13%

ROA:2.69%

PB:1.09

PE(LYR):35.47

PS:2.44

Loading ...

Overview Company News Filings

Sihuan Pharmaceutical Returns to Profitability with FY Net Income of 180 Million Yuan

Sihuan Pharmaceutical 2025 Results: Revenue Climbs 37.7%, Turns Profitable on Medical Aesthetics Surge

Bulletin Express

Sihuan Pharma FY25 revenue climbs 37.7% to RMB 2.6 billion

Sihuan Pharma - FY Profit Attributable RMB179.7 Mln

THOMSON REUTERS

Sihuan Pharma - Final Cash Dividend of RMB0.96 Cents per Share

THOMSON REUTERS

Xuanzhu Biopharma FY25 loss narrows 55.9% to RMB 250 million

Sihuan Pharmaceutical unit publishes BRIGHT-2 Phase 3 results for biloxcilib plus fulvestrant in JAMA Oncology

Xuanzhu Biopharmaceutical reports BRIGHT-2 Phase 3 results for Bireociclib plus fulvestrant in HR+/HER2- breast cancer

Xuanzhu Biopharmaceutical completes enrollment of 500 patients in China Phase 3 trial of anaprazole sodium enteric-coated tablets for reflux esophagitis

Xuanzhu Biopharmaceutical completes enrollment of 500 subjects in China Phase III reflux esophagitis trial of anaprazole sodium tablets

Sihuan Pharma (00460) Schedules 31 Mar 2026 Board Meeting to Approve FY2025 Results and Consider Final Dividend

Bulletin Express

Assessing Sihuan Pharmaceutical Holdings Group’s Valuation After Bireociclib’s New First Line Breast Cancer Approval

Simply Wall St.

Sihuan Pharmaceutical affiliate Xuanzhu Biopharm enters Hong Kong Stock Connect list

SIHUAN PHARM (00460) Rises Over 5% in Morning Session as Xuan Yue Ning® Gains Third Indication Approval from NMPA

BRIEF-Sihuan Pharma Reports Marketing Approval For Bireociclib Tablets Granted By NMPA

Sihuan Pharmaceutical (0460) Gains NMPA Approval for Third Indication of Bireociclib in First-Line HR+/HER2- Advanced Breast Cancer

Bulletin Express

Sihuan Pharma - Marketing Approval for Bireociclib Tablets Granted by Nmpa

THOMSON REUTERS

China NMPA grants Xuanzhu Biopharmaceutical approval for Xuanyuening in first-line HR+/HER2- advanced breast cancer

Sihuan Pharmaceutical (00460) Publishes February 2026 Monthly Return, Confirms Public Float Compliance

Bulletin Express

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/stock/00460/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"00460","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"00460\",,,,,undefined,":{"symbol":"00460","market":"HK","secType":"STK","nameCN":"SIHUAN PHARM","latestPrice":0.815,"timestamp":1787731683002,"preClose":0.87,"halted":0,"volume":105267000,"delay":0,"changeRate":-0.06321839080459776,"floatShares":9126000000,"shares":9126000000,"eps":0.022977310568646814,"marketStatus":"Not Yet Opened","change":-0.055,"latestTime":"08-26 16:08:03","open":0.87,"high":0.895,"low":0.81,"amount":88920967,"amplitude":0.097701,"askPrice":0.82,"askSize":2847000,"bidPrice":0.815,"bidSize":1745000,"shortable":3,"etf":0,"ttmEps":0.022976144207704243,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1787794200000},"marketStatusCode":0,"adr":0,"listingDate":1288195200000,"exchange":"SEHK","adjPreClose":0.87,"dividendRate":0.027574,"openAndCloseTimeList":[[1787707800000,1787716800000],[1787720400000,1787731200000]],"volumeRatio":3.15079357363609,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"00460\",,,,,undefined,":{"symbol":"00460","floatShares":9126000000,"roa":"2.69%","roe":"3.13%","lyrEps":0.022977,"volumeRatio":3.15079357363609,"shares":9126000000,"dividePrice":0.022744,"high":0.895,"amplitude":0.097701,"preClose":0.87,"low":0.81,"week52Low":0.81,"pbRate":"1.09","psRate":"2.44","week52High":1.896,"institutionHeld":0,"latestPrice":0.815,"committee":-0.239983,"eps":0.022977310568646814,"divideRate":0.027907,"volume":105267000,"delay":0,"ttmEps":0.022976144207704243,"open":0.87,"prevYearClose":1.215,"prevWeekClose":0.875,"prevMonthClose":0.9,"prevQuarterClose":0.83,"fiveDayClose":0.85,"twentyDayClose":0.93,"sixtyDayClose":0.958,"dividendGrowthYears":0,"dividendGrowthRate":-0.48095238095238096,"fiveYearAvgDividendRate":0.06241727605023266},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/00460\",params:#limit:5,,,undefined,":[{"date":"2026-08-26","symbol":"00460","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787707800000,"name":null,"time":"","dateTimestamp":1787673600000,"actualEps":null},{"date":"2026-06-30","symbol":"00460","amount":0.0109,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"HK","newRecordDate":"2026-07-02","defaultRemindTime":1782783000000,"name":"四环医药","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-07-16","payableDate":"2026-07-02","currency":"HKD","dateTimestamp":1782748800000,"payDate":"2026-07-16"},{"market":"HK","date":"2026-03-31","symbol":"00460","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1774886400000,"reportTimeType":"pre","actualEps":null},{"date":"2025-09-26","symbol":"00460","amount":0.0109,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"HK","newRecordDate":"2025-09-29","defaultRemindTime":1758850200000,"name":"四环医药","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-10-10","payableDate":"2025-09-29","currency":"HKD","dateTimestamp":1758816000000,"payDate":"2025-10-10"},{"date":"2025-08-29","symbol":"00460","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756431000000,"name":null,"time":"","dateTimestamp":1756396800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"00460\",market:\"HK\",,,undefined,":[{"executeDate":"2016-09-05","recordDate":"2016-09-06","paymentDate":"2016-09-15","value":0.016,"currency":"HKD"},{"executeDate":"2017-06-22","recordDate":"2017-06-23","paymentDate":"2017-07-05","value":0.061,"currency":"HKD"},{"executeDate":"2017-09-01","recordDate":"2017-09-04","paymentDate":"2017-09-13","value":0.021,"currency":"HKD"},{"executeDate":"2018-06-07","recordDate":"2018-06-08","paymentDate":"2018-06-20","value":0.016,"currency":"HKD"},{"executeDate":"2018-10-18","recordDate":"2018-10-19","paymentDate":"2018-10-31","value":0.005,"currency":"HKD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"00460\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":1,"buy":0,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":1,"analysts":1,"updateTime":1776182400000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/00460\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"00460","date":"2026-08-26","current":35.472528,"percent":0.918633,"low":-209.490836,"twenty":-129.677118,"median":-26.436082,"eighty":13.630989,"high":64.244472,"avg":-43.644161,"sd":66.634768,"marketCap":7352767167},"quantilePoints":[{"date":"2021-08-27","current":35.494026,"twenty":-27.877152,"median":40.988008,"eighty":51.61407,"marketCap":20220393920},{"date":"2021-09-03","current":18.974009,"twenty":-25.966242,"median":39.047216,"eighty":51.471473,"marketCap":21354247785},{"date":"2021-09-10","current":18.339152,"twenty":-25.715994,"median":38.415307,"eighty":51.182712,"marketCap":20692833031},{"date":"2021-09-17","current":17.797528,"twenty":-25.433432,"median":37.439142,"eighty":51.151715,"marketCap":20022302276},{"date":"2021-09-24","current":16.774147,"twenty":-24.842427,"median":37.187111,"eighty":50.92554,"marketCap":18879724412},{"date":"2021-09-30","current":13.865815,"twenty":-23.806841,"median":36.949192,"eighty":50.630372,"marketCap":15658551261},{"date":"2021-10-08","current":13.108229,"twenty":-22.959741,"median":35.979756,"eighty":50.46473,"marketCap":14802340263},{"date":"2021-10-15","current":13.579123,"twenty":-21.594681,"median":35.600566,"eighty":50.364548,"marketCap":15344610065},{"date":"2021-10-22","current":14.332089,"twenty":-19.026938,"median":35.395632,"eighty":50.002562,"marketCap":16311750418},{"date":"2021-10-29","current":13.511153,"twenty":-15.708182,"median":35.247968,"eighty":49.588904,"marketCap":15339395937},{"date":"2021-11-05","current":12.246285,"twenty":-12.19519,"median":34.988251,"eighty":49.223932,"marketCap":13926283816},{"date":"2021-11-12","current":12.011055,"twenty":-11.77144,"median":27.258382,"eighty":48.839902,"marketCap":13715098832},{"date":"2021-11-19","current":12.928135,"twenty":-11.732461,"median":19.402854,"eighty":48.776182,"marketCap":14741398745},{"date":"2021-11-26","current":13.414784,"twenty":-11.673993,"median":19.144523,"eighty":48.710704,"marketCap":15301198697},{"date":"2021-12-03","current":12.246976,"twenty":-11.652916,"median":18.619604,"eighty":48.61427,"marketCap":13994998809},{"date":"2021-12-10","current":12.796652,"twenty":-11.595138,"median":18.005665,"eighty":48.548604,"marketCap":14648098753},{"date":"2021-12-17","current":11.500484,"twenty":-11.464523,"median":17.782952,"eighty":48.516654,"marketCap":13155298880},{"date":"2021-12-24","current":11.652483,"twenty":-11.370198,"median":17.227082,"eighty":48.404807,"marketCap":13341898864},{"date":"2021-12-31","current":12.033737,"twenty":-11.352806,"median":16.727584,"eighty":48.276843,"marketCap":13808398824},{"date":"2022-01-07","current":11.997981,"twenty":11.916847,"median":12.033737,"eighty":12.311613,"marketCap":13715098832},{"date":"2022-01-14","current":13.437855,"twenty":11.991179,"median":12.354107,"eighty":13.277084,"marketCap":15394498689},{"date":"2022-01-21","current":12.838373,"twenty":12.019435,"median":12.923546,"eighty":13.260333,"marketCap":14741398745},{"date":"2022-01-28","current":11.730737,"twenty":11.950402,"median":12.53206,"eighty":13.186191,"marketCap":13435198856},{"date":"2022-02-04","current":12.062504,"twenty":11.904542,"median":12.319594,"eighty":13.174667,"marketCap":13808398824},{"date":"2022-02-11","current":13.095597,"twenty":11.980976,"median":12.566572,"eighty":13.174667,"marketCap":15021298721},{"date":"2022-02-18","current":14.893251,"twenty":11.997981,"median":12.857781,"eighty":13.345619,"marketCap":17167198539},{"date":"2022-02-25","current":13.968456,"twenty":12.033737,"median":12.929214,"eighty":13.75323,"marketCap":16140898626},{"date":"2022-03-04","current":12.913857,"twenty":12.062504,"median":12.988177,"eighty":13.600429,"marketCap":14927998729},{"date":"2022-03-11","current":13.175885,"twenty":12.074235,"median":12.990943,"eighty":13.53943,"marketCap":15207898705},{"date":"2022-03-18","current":13.228631,"twenty":12.062504,"median":12.970168,"eighty":13.471303,"marketCap":15207898705},{"date":"2022-03-25","current":13.390384,"twenty":12.074235,"median":13.001622,"eighty":13.556612,"marketCap":15394498689},{"date":"2022-04-01","current":28.56237,"twenty":12.077655,"median":13.05005,"eighty":13.891083,"marketCap":14648098753},{"date":"2022-04-08","current":27.095221,"twenty":12.083977,"median":13.125304,"eighty":14.447354,"marketCap":13901698816},{"date":"2022-04-14","current":25.865073,"twenty":12.119208,"median":13.175276,"eighty":14.953028,"marketCap":13248598872},{"date":"2022-04-22","current":24.501555,"twenty":12.191086,"median":13.216054,"eighty":20.896029,"marketCap":12315598951},{"date":"2022-04-29","current":23.770426,"twenty":12.311154,"median":13.345619,"eighty":23.810765,"marketCap":11755798999},{"date":"2022-05-06","current":19.97461,"twenty":12.403513,"median":13.387495,"eighty":23.824211,"marketCap":9796499166},{"date":"2022-05-13","current":22.275517,"twenty":12.497547,"median":13.437855,"eighty":23.770426,"marketCap":10729499086},{"date":"2022-05-20","current":23.495458,"twenty":12.566572,"median":13.505367,"eighty":23.495458,"marketCap":11475899023},{"date":"2022-05-27","current":20.456885,"twenty":12.635159,"median":13.600429,"eighty":23.495458,"marketCap":9983099150},{"date":"2022-06-02","current":22.059164,"twenty":12.719893,"median":13.891083,"eighty":23.428031,"marketCap":10822799078},{"date":"2022-06-10","current":22.782826,"twenty":12.818914,"median":14.187223,"eighty":23.405861,"marketCap":11102699055},{"date":"2022-06-17","current":22.61617,"twenty":12.869426,"median":14.893251,"eighty":23.399001,"marketCap":11009399063},{"date":"2022-06-24","current":24.053703,"twenty":12.896899,"median":15.198068,"eighty":23.405861,"marketCap":11755798999},{"date":"2022-06-30","current":24.477649,"twenty":12.909045,"median":17.731175,"eighty":23.688539,"marketCap":11942398983},{"date":"2022-07-08","current":24.643513,"twenty":12.91967,"median":20.576157,"eighty":24.071679,"marketCap":12035698975},{"date":"2022-07-15","current":21.788884,"twenty":12.926947,"median":21.331232,"eighty":24.071679,"marketCap":10542899102},{"date":"2022-07-22","current":22.738077,"twenty":12.951049,"median":21.927975,"eighty":23.924075,"marketCap":11009399063},{"date":"2022-07-29","current":21.55561,"twenty":12.971081,"median":21.986908,"eighty":23.797318,"marketCap":10449599110},{"date":"2022-08-05","current":21.417702,"twenty":12.984459,"median":21.788884,"eighty":23.729375,"marketCap":10356299118},{"date":"2022-08-12","current":21.388554,"twenty":12.99735,"median":21.539113,"eighty":23.688539,"marketCap":10356299118},{"date":"2022-08-19","current":19.074515,"twenty":13.008905,"median":21.417702,"eighty":23.569099,"marketCap":9143399221},{"date":"2022-08-26","current":20.011662,"twenty":13.057307,"median":21.382076,"eighty":23.444888,"marketCap":9516599190},{"date":"2022-09-02","current":-50.414444,"twenty":12.984459,"median":21.247144,"eighty":23.407189,"marketCap":8863499245},{"date":"2022-09-09","current":-50.607103,"twenty":12.91967,"median":20.858756,"eighty":23.400384,"marketCap":8863499245},{"date":"2022-09-16","current":-47.853042,"twenty":12.853899,"median":20.604805,"eighty":23.393338,"marketCap":8303699293},{"date":"2022-09-23","current":-43.307663,"twenty":12.525157,"median":20.456885,"eighty":23.36815,"marketCap":7370699372},{"date":"2022-09-30","current":-41.583628,"twenty":12.107991,"median":19.993136,"eighty":23.33352,"marketCap":7090799396},{"date":"2022-10-07","current":-42.133205,"twenty":12.06485,"median":19.637124,"eighty":23.316565,"marketCap":7184099388},{"date":"2022-10-14","current":-40.925738,"twenty":11.919829,"median":19.38703,"eighty":23.276922,"marketCap":6904199412},{"date":"2022-10-21","current":-41.207935,"twenty":11.75473,"median":18.999282,"eighty":23.214673,"marketCap":6904199412},{"date":"2022-10-28","current":-37.373897,"twenty":-27.390428,"median":15.48774,"eighty":23.127451,"marketCap":6251099468},{"date":"2022-11-04","current":-43.090604,"twenty":-38.423466,"median":14.959982,"eighty":23.068326,"marketCap":7277399380},{"date":"2022-11-11","current":-44.352681,"twenty":-39.706495,"median":14.612812,"eighty":22.970466,"marketCap":7557299356},{"date":"2022-11-18","current":-49.450162,"twenty":-40.88532,"median":13.933713,"eighty":22.927159,"marketCap":8396999285},{"date":"2022-11-25","current":-45.968734,"twenty":-42.005475,"median":13.75323,"eighty":22.88204,"marketCap":7743899340},{"date":"2022-12-02","current":-46.277717,"twenty":-42.783845,"median":13.548021,"eighty":22.8258,"marketCap":7930499325},{"date":"2022-12-09","current":-49.088418,"twenty":-43.299013,"median":13.457621,"eighty":22.784854,"marketCap":8490299277},{"date":"2022-12-16","current":-50.825271,"twenty":-44.19667,"median":13.388939,"eighty":22.776063,"marketCap":8770199253},{"date":"2022-12-23","current":-48.647344,"twenty":-44.632402,"median":13.345619,"eighty":22.746825,"marketCap":8396999285},{"date":"2022-12-30","current":-50.733601,"twenty":-44.88627,"median":13.246799,"eighty":22.740264,"marketCap":8863499245},{"date":"2023-01-06","current":-53.389335,"twenty":-45.265509,"median":13.18968,"eighty":22.735439,"marketCap":9423299198},{"date":"2023-01-13","current":-53.424808,"twenty":-45.938929,"median":13.15501,"eighty":22.731574,"marketCap":9609899182},{"date":"2023-01-20","current":-52.840862,"twenty":-46.59674,"median":13.05005,"eighty":22.727682,"marketCap":9423299198},{"date":"2023-01-27","current":-54.922334,"twenty":-47.03062,"median":13.007691,"eighty":22.726024,"marketCap":9796499166},{"date":"2023-02-03","current":-57.761641,"twenty":-47.472906,"median":12.974732,"eighty":22.707873,"marketCap":10356299118},{"date":"2023-02-10","current":-52.875612,"twenty":-47.832379,"median":12.92638,"eighty":22.61617,"marketCap":9423299198},{"date":"2023-02-17","current":-50.737918,"twenty":-48.647344,"median":12.901826,"eighty":22.608311,"marketCap":8956799237},{"date":"2023-02-24","current":-49.760718,"twenty":-49.165946,"median":12.789725,"eighty":22.583157,"marketCap":8676899261},{"date":"2023-03-03","current":-51.036808,"twenty":-49.265743,"median":12.566572,"eighty":22.527072,"marketCap":8956799237},{"date":"2023-03-10","current":-43.382514,"twenty":-48.330408,"median":-46.012402,"eighty":-43.703866,"marketCap":7557299356},{"date":"2023-03-17","current":-43.497246,"twenty":-11.799375,"median":9.135444,"eighty":13.964446,"marketCap":7650599348},{"date":"2023-03-24","current":-43.003515,"twenty":-11.923183,"median":9.108489,"eighty":13.964446,"marketCap":7650599348},{"date":"2023-03-31","current":-3.369265,"twenty":-11.914105,"median":9.06444,"eighty":13.922755,"marketCap":7370699372},{"date":"2023-04-06","current":-3.499469,"twenty":-11.905028,"median":9.059545,"eighty":13.910863,"marketCap":7650599348},{"date":"2023-04-14","current":-3.62392,"twenty":-11.923183,"median":8.997567,"eighty":13.934648,"marketCap":7930499325},{"date":"2023-04-21","current":-3.412504,"twenty":-11.923183,"median":8.985211,"eighty":13.934648,"marketCap":7463999364},{"date":"2023-04-28","current":-3.438104,"twenty":-11.923183,"median":8.941609,"eighty":13.934648,"marketCap":7463999364},{"date":"2023-05-05","current":-3.475381,"twenty":-11.923183,"median":8.913332,"eighty":13.934648,"marketCap":7557299356},{"date":"2023-05-12","current":-3.369868,"twenty":-11.923183,"median":8.886738,"eighty":13.934648,"marketCap":7277399380},{"date":"2023-05-19","current":-3.374111,"twenty":-11.923183,"median":8.84028,"eighty":13.934648,"marketCap":7184099388},{"date":"2023-05-25","current":-3.344052,"twenty":-11.914105,"median":8.76622,"eighty":13.922755,"marketCap":7090799396},{"date":"2023-06-02","current":-3.399581,"twenty":-11.923183,"median":8.634294,"eighty":13.934648,"marketCap":7184099388},{"date":"2023-06-09","current":-3.271849,"twenty":-11.923183,"median":8.544591,"eighty":13.934648,"marketCap":6904199412},{"date":"2023-06-16","current":-3.287594,"twenty":-11.923183,"median":8.325238,"eighty":13.934648,"marketCap":6904199412},{"date":"2023-06-23","current":-3.260953,"twenty":-11.923183,"median":8.22569,"eighty":13.934648,"marketCap":6810899420},{"date":"2023-06-30","current":-3.516112,"twenty":-11.923183,"median":8.122554,"eighty":13.934648,"marketCap":7277399380},{"date":"2023-07-07","current":-3.387485,"twenty":-11.914105,"median":8.052356,"eighty":13.922755,"marketCap":6997499404},{"date":"2023-07-14","current":-3.296067,"twenty":-11.914105,"median":7.77723,"eighty":13.922755,"marketCap":6904199412},{"date":"2023-07-21","current":-3.311457,"twenty":-11.914105,"median":7.356217,"eighty":13.922755,"marketCap":6904199412},{"date":"2023-07-28","current":-3.449398,"twenty":-11.914105,"median":-2.287019,"eighty":13.922755,"marketCap":7184099388},{"date":"2023-08-04","current":-3.264781,"twenty":-11.914105,"median":-2.31585,"eighty":13.922755,"marketCap":6810899420},{"date":"2023-08-11","current":-3.28332,"twenty":-11.914105,"median":-2.324398,"eighty":13.922755,"marketCap":6810899420},{"date":"2023-08-18","current":-2.899285,"twenty":-11.914105,"median":-2.339675,"eighty":13.922755,"marketCap":5971199491},{"date":"2023-08-25","current":-2.988413,"twenty":-11.914105,"median":-2.355562,"eighty":13.922755,"marketCap":6157799475},{"date":"2023-09-01","current":-2.756299,"twenty":-11.914105,"median":-2.368431,"eighty":13.922755,"marketCap":5971199491},{"date":"2023-09-08","current":-2.832715,"twenty":-11.914105,"median":-2.388209,"eighty":13.922755,"marketCap":6064499483},{"date":"2023-09-15","current":-2.854165,"twenty":-11.914105,"median":-2.395927,"eighty":13.922755,"marketCap":6157799475},{"date":"2023-09-22","current":-2.779829,"twenty":-11.914105,"median":-2.415497,"eighty":13.922755,"marketCap":5971199491},{"date":"2023-09-29","current":-2.644988,"twenty":-11.905028,"median":-2.420333,"eighty":13.910863,"marketCap":5691299515},{"date":"2023-10-06","current":-2.602874,"twenty":-11.905028,"median":-2.422655,"eighty":13.910863,"marketCap":5597999523},{"date":"2023-10-13","current":-2.737106,"twenty":-11.905028,"median":-2.427741,"eighty":13.910863,"marketCap":5877899499},{"date":"2023-10-20","current":-2.654304,"twenty":-11.89595,"median":-2.443134,"eighty":13.898971,"marketCap":5691299515},{"date":"2023-10-27","current":-2.655443,"twenty":-11.905028,"median":-2.448372,"eighty":13.910863,"marketCap":5691299515},{"date":"2023-11-03","current":-2.908911,"twenty":-11.905028,"median":-2.473666,"eighty":13.910863,"marketCap":6251099468},{"date":"2023-11-10","current":-2.866093,"twenty":-11.905028,"median":-2.484636,"eighty":13.910863,"marketCap":6157799475},{"date":"2023-11-17","current":-2.883513,"twenty":-11.905028,"median":-2.491565,"eighty":13.910863,"marketCap":6251099468},{"date":"2023-11-24","current":-2.988026,"twenty":-11.905028,"median":-2.505676,"eighty":13.910863,"marketCap":6530999444},{"date":"2023-12-01","current":-2.848158,"twenty":-11.905028,"median":-2.536149,"eighty":13.910863,"marketCap":6251099468},{"date":"2023-12-08","current":-2.646304,"twenty":-11.905028,"median":-2.561957,"eighty":13.910863,"marketCap":5784599507},{"date":"2023-12-15","current":-2.673547,"twenty":-11.905028,"median":-2.583157,"eighty":13.910863,"marketCap":5877899499},{"date":"2023-12-22","current":-2.632869,"twenty":-11.905028,"median":-2.607761,"eighty":13.910863,"marketCap":5784599507},{"date":"2023-12-29","current":-2.745627,"twenty":-11.905028,"median":-2.60984,"eighty":13.910863,"marketCap":6064499483},{"date":"2024-01-05","current":-2.637506,"twenty":-11.905028,"median":-2.639856,"eighty":13.910863,"marketCap":5784599507},{"date":"2024-01-12","current":-2.678621,"twenty":-11.905028,"median":-2.644988,"eighty":13.910863,"marketCap":5877899499},{"date":"2024-01-19","current":-2.426848,"twenty":-11.905028,"median":-2.646304,"eighty":13.910863,"marketCap":5318099547},{"date":"2024-01-26","current":-2.479072,"twenty":-11.905028,"median":-2.646304,"eighty":13.910863,"marketCap":5411399539},{"date":"2024-02-02","current":-2.182657,"twenty":-11.905028,"median":-2.646304,"eighty":13.910863,"marketCap":4758299595},{"date":"2024-02-09","current":-2.342311,"twenty":-11.895406,"median":-2.644096,"eighty":13.898608,"marketCap":5131499563},{"date":"2024-02-16","current":-2.384382,"twenty":-11.89595,"median":-2.645646,"eighty":13.898971,"marketCap":5224799555},{"date":"2024-02-23","current":-2.482626,"twenty":-11.89595,"median":-2.645646,"eighty":13.898971,"marketCap":5411399539},{"date":"2024-03-01","current":-2.438302,"twenty":-11.895678,"median":-2.644988,"eighty":13.89879,"marketCap":5318099547},{"date":"2024-03-08","current":-2.351702,"twenty":-11.895678,"median":-2.644988,"eighty":13.89879,"marketCap":5131499563},{"date":"2024-03-15","current":-2.482173,"twenty":-11.895678,"median":-2.644988,"eighty":13.89879,"marketCap":5411399539},{"date":"2024-03-22","current":-2.441611,"twenty":-11.895678,"median":-2.644988,"eighty":13.89879,"marketCap":5318099547},{"date":"2024-03-28","current":-2.277553,"twenty":-11.895678,"median":-2.644988,"eighty":13.89879,"marketCap":4944899579},{"date":"2024-04-05","current":-82.564306,"twenty":-12.024696,"median":-2.653901,"eighty":13.922755,"marketCap":4826414427},{"date":"2024-04-12","current":-82.517453,"twenty":-12.053439,"median":-2.678022,"eighty":13.910863,"marketCap":4826414427},{"date":"2024-04-19","current":-80.999729,"twenty":-12.172703,"median":-2.681735,"eighty":13.910863,"marketCap":4733598765},{"date":"2024-04-26","current":-89.050676,"twenty":-12.294617,"median":-2.696365,"eighty":13.89879,"marketCap":5197677075},{"date":"2024-05-03","current":-97.068727,"twenty":-12.347799,"median":-2.720997,"eighty":13.89879,"marketCap":5661755385},{"date":"2024-05-10","current":-100.013862,"twenty":-12.43199,"median":-2.742169,"eighty":13.89879,"marketCap":5847386709},{"date":"2024-05-17","current":-96.981169,"twenty":-12.561565,"median":-2.775562,"eighty":13.89879,"marketCap":5661755385},{"date":"2024-05-24","current":-90.829186,"twenty":-12.802369,"median":-2.783534,"eighty":13.89879,"marketCap":5290492737},{"date":"2024-05-31","current":-85.961213,"twenty":-12.9722,"median":-2.82109,"eighty":13.89879,"marketCap":5012045751},{"date":"2024-06-07","current":-82.880248,"twenty":-13.0747,"median":-2.850331,"eighty":13.89879,"marketCap":4826414427},{"date":"2024-06-14","current":-89.337509,"twenty":-13.162465,"median":-2.855147,"eighty":13.89879,"marketCap":5197677075},{"date":"2024-06-21","current":-87.926264,"twenty":-13.350566,"median":-2.866093,"eighty":13.89879,"marketCap":5104861413},{"date":"2024-06-28","current":-83.075186,"twenty":-13.539773,"median":-2.899285,"eighty":13.89879,"marketCap":4821214427},{"date":"2024-07-05","current":-87.887073,"twenty":-13.831871,"median":-2.914912,"eighty":13.89879,"marketCap":5099361413},{"date":"2024-07-12","current":-89.353766,"twenty":-23.129881,"median":-2.937581,"eighty":13.89879,"marketCap":5192077075},{"date":"2024-07-19","current":-87.75652,"twenty":-27.49497,"median":-2.962287,"eighty":13.89879,"marketCap":5099361413},{"date":"2024-07-26","current":-82.662699,"twenty":-29.481842,"median":-2.988026,"eighty":13.89879,"marketCap":4821214427},{"date":"2024-08-02","current":-82.710896,"twenty":-31.051397,"median":-2.992606,"eighty":13.89879,"marketCap":4821214427},{"date":"2024-08-09","current":-83.743358,"twenty":-31.528775,"median":-3.16992,"eighty":13.89879,"marketCap":4913930089},{"date":"2024-08-16","current":-85.290276,"twenty":-32.152303,"median":-3.229351,"eighty":13.89879,"marketCap":5006645751},{"date":"2024-08-23","current":-83.358505,"twenty":-32.890641,"median":-3.231225,"eighty":13.89879,"marketCap":4913930089},{"date":"2024-08-30","current":-84.364924,"twenty":-35.838782,"median":-3.231225,"eighty":13.89879,"marketCap":5006645751},{"date":"2024-09-06","current":-122.742481,"twenty":-37.338415,"median":-3.231225,"eighty":13.89879,"marketCap":5099361413},{"date":"2024-09-13","current":-116.352005,"twenty":-39.121822,"median":-3.231225,"eighty":13.89879,"marketCap":4821214427},{"date":"2024-09-20","current":-120.106819,"twenty":-40.50159,"median":-3.230288,"eighty":13.898971,"marketCap":5006645751},{"date":"2024-09-27","current":-128.90228,"twenty":-41.473142,"median":-3.230288,"eighty":13.898971,"marketCap":5405599539},{"date":"2024-10-04","current":-160.746776,"twenty":-42.353423,"median":-3.230288,"eighty":13.898971,"marketCap":6710399428},{"date":"2024-10-10","current":-166.288706,"twenty":-42.783845,"median":-3.231225,"eighty":13.89879,"marketCap":6896799412},{"date":"2024-10-18","current":-160.383543,"twenty":-43.090604,"median":-3.230288,"eighty":13.898971,"marketCap":6617199436},{"date":"2024-10-25","current":-160.393712,"twenty":-43.385987,"median":-3.230288,"eighty":13.898971,"marketCap":6617199436},{"date":"2024-11-01","current":-162.543207,"twenty":-43.918101,"median":-3.230288,"eighty":13.898971,"marketCap":6710399428},{"date":"2024-11-08","current":-165.551727,"twenty":-44.601068,"median":-3.230288,"eighty":13.898971,"marketCap":6803599420},{"date":"2024-11-15","current":-153.57094,"twenty":-45.087779,"median":-3.230288,"eighty":13.898971,"marketCap":6244399468},{"date":"2024-11-22","current":-151.350528,"twenty":-45.919059,"median":-3.230288,"eighty":13.898971,"marketCap":6151199475},{"date":"2024-11-29","current":-158.1664,"twenty":-46.947732,"median":-3.230288,"eighty":13.898971,"marketCap":6423899452},{"date":"2024-12-06","current":-158.539828,"twenty":-47.472906,"median":-3.230288,"eighty":13.898971,"marketCap":6423899452},{"date":"2024-12-13","current":-156.551131,"twenty":-47.853042,"median":-3.230288,"eighty":13.898971,"marketCap":6330799460},{"date":"2024-12-20","current":-152.622975,"twenty":-48.647344,"median":-3.230288,"eighty":13.898971,"marketCap":6144599475},{"date":"2024-12-27","current":-150.427207,"twenty":-48.748259,"median":-3.230288,"eighty":13.898971,"marketCap":6051499483},{"date":"2025-01-03","current":-145.65607,"twenty":-49.231765,"median":-3.230288,"eighty":13.898971,"marketCap":5865299499},{"date":"2025-01-10","current":-134.606092,"twenty":-49.760718,"median":-3.230288,"eighty":13.898971,"marketCap":5399799539},{"date":"2025-01-17","current":-134.497552,"twenty":-50.352943,"median":-3.230288,"eighty":13.898971,"marketCap":5399799539},{"date":"2025-01-24","current":-131.355559,"twenty":-50.737918,"median":-3.230288,"eighty":13.898971,"marketCap":5306699547},{"date":"2025-01-28","current":-135.255702,"twenty":-50.821082,"median":-3.231225,"eighty":13.89879,"marketCap":5492899531},{"date":"2025-02-07","current":-133.7198,"twenty":-51.348886,"median":-3.229351,"eighty":13.910863,"marketCap":5399799539},{"date":"2025-02-14","current":-143.010767,"twenty":-51.820483,"median":-3.229351,"eighty":13.910863,"marketCap":5772199507},{"date":"2025-02-21","current":-140.204067,"twenty":-52.541209,"median":-3.229351,"eighty":13.910863,"marketCap":5679099515},{"date":"2025-02-28","current":-136.055611,"twenty":-52.889352,"median":-3.229351,"eighty":13.910863,"marketCap":5492899531},{"date":"2025-03-07","current":-140.105142,"twenty":-53.292951,"median":-3.228493,"eighty":13.922755,"marketCap":5679099515},{"date":"2025-03-14","current":-137.758216,"twenty":-53.706159,"median":-3.228493,"eighty":13.922755,"marketCap":5585999523},{"date":"2025-03-21","current":-146.841923,"twenty":-54.405044,"median":-3.228493,"eighty":13.922755,"marketCap":5951999491},{"date":"2025-03-28","current":-137.943443,"twenty":-56.391895,"median":-3.241626,"eighty":13.922755,"marketCap":5579999523},{"date":"2025-04-03","current":-26.523264,"twenty":-56.391895,"median":-3.251132,"eighty":13.922755,"marketCap":6137999475},{"date":"2025-04-11","current":-25.486974,"twenty":-56.391895,"median":-3.265745,"eighty":13.922755,"marketCap":5858999499},{"date":"2025-04-17","current":-25.150028,"twenty":-56.370327,"median":-3.279167,"eighty":13.910863,"marketCap":5795411709},{"date":"2025-04-25","current":-26.324914,"twenty":-56.413464,"median":-3.301031,"eighty":13.934648,"marketCap":6071383695},{"date":"2025-05-02","current":-29.45321,"twenty":-56.391895,"median":-3.309311,"eighty":13.922755,"marketCap":6807308992},{"date":"2025-05-09","current":-27.542361,"twenty":-56.413464,"median":-3.312987,"eighty":13.934648,"marketCap":6410355844},{"date":"2025-05-16","current":-26.119791,"twenty":-56.413464,"median":-3.359803,"eighty":13.934648,"marketCap":6128926308},{"date":"2025-05-23","current":-34.592965,"twenty":-56.413464,"median":-3.369868,"eighty":13.934648,"marketCap":8141409573},{"date":"2025-05-30","current":-37.924397,"twenty":-56.413464,"median":-3.387485,"eighty":13.934648,"marketCap":8964698181},{"date":"2025-06-06","current":-39.757882,"twenty":-56.413464,"median":-3.411914,"eighty":13.934648,"marketCap":9422080742},{"date":"2025-06-13","current":-44.75817,"twenty":-56.413464,"median":-3.415949,"eighty":13.934648,"marketCap":10611275398},{"date":"2025-06-20","current":-41.276192,"twenty":-56.413464,"median":-3.420731,"eighty":13.934648,"marketCap":9766586790},{"date":"2025-06-27","current":-42.699652,"twenty":-56.391895,"median":-3.438104,"eighty":13.922755,"marketCap":10131692838},{"date":"2025-07-04","current":-41.543655,"twenty":-56.391895,"median":-3.44468,"eighty":13.922755,"marketCap":9857863302},{"date":"2025-07-11","current":-46.206161,"twenty":-56.391895,"median":-3.469159,"eighty":13.922755,"marketCap":10953181447},{"date":"2025-07-18","current":-53.564112,"twenty":-56.391895,"median":-3.482303,"eighty":13.922755,"marketCap":12687435176},{"date":"2025-07-25","current":-51.066284,"twenty":-56.391895,"median":-3.514529,"eighty":13.922755,"marketCap":12139776103},{"date":"2025-08-01","current":-50.22475,"twenty":-56.391895,"median":-3.589151,"eighty":13.922755,"marketCap":11865946567},{"date":"2025-08-08","current":-53.18247,"twenty":-56.391895,"median":-7.200248,"eighty":13.922755,"marketCap":12596158664},{"date":"2025-08-15","current":-55.192072,"twenty":-56.391895,"median":-11.122318,"eighty":13.922755,"marketCap":13052541224},{"date":"2025-08-22","current":-55.752863,"twenty":-57.774713,"median":-11.335383,"eighty":13.922755,"marketCap":13143817736},{"date":"2025-08-29","current":-56.258629,"twenty":-57.774713,"median":-11.34716,"eighty":13.922755,"marketCap":13326370760},{"date":"2025-09-05","current":-171.005462,"twenty":-80.999729,"median":-11.34716,"eighty":13.922755,"marketCap":15060624489},{"date":"2025-09-12","current":-173.767346,"twenty":-82.276481,"median":-11.34716,"eighty":13.922755,"marketCap":15331415304},{"date":"2025-09-19","current":-169.725699,"twenty":-82.58333,"median":-11.34716,"eighty":13.922755,"marketCap":14964195775},{"date":"2025-09-26","current":-153.463683,"twenty":-82.851859,"median":-11.34716,"eighty":13.922755,"marketCap":13495317662},{"date":"2025-10-03","current":-185.056471,"twenty":-83.064154,"median":-11.352265,"eighty":13.910863,"marketCap":16312368818},{"date":"2025-10-10","current":-169.796368,"twenty":-83.220688,"median":-11.348775,"eighty":13.922755,"marketCap":14945410537},{"date":"2025-10-17","current":-151.277947,"twenty":-83.756141,"median":-11.37254,"eighty":13.922755,"marketCap":13305060600},{"date":"2025-10-24","current":-146.676373,"twenty":-84.447774,"median":-11.37254,"eighty":13.922755,"marketCap":12905038392},{"date":"2025-10-31","current":-152.64629,"twenty":-84.624193,"median":-11.37254,"eighty":13.922755,"marketCap":13450321704},{"date":"2025-11-07","current":-144.485392,"twenty":-85.250381,"median":-11.37254,"eighty":13.922755,"marketCap":12723277288},{"date":"2025-11-14","current":-147.164496,"twenty":-85.777895,"median":-11.37254,"eighty":13.922755,"marketCap":12995918944},{"date":"2025-11-21","current":-133.84826,"twenty":-86.066041,"median":-11.37254,"eighty":13.922755,"marketCap":11814471767},{"date":"2025-11-28","current":-138.493216,"twenty":-86.277112,"median":-11.37254,"eighty":13.922755,"marketCap":12268874528},{"date":"2025-12-05","current":-136.207289,"twenty":-87.682255,"median":-11.37254,"eighty":13.922755,"marketCap":12087113423},{"date":"2025-12-12","current":-133.911368,"twenty":-87.902749,"median":-11.37254,"eighty":13.922755,"marketCap":11905352319},{"date":"2025-12-19","current":-128.497409,"twenty":-89.023351,"median":-11.37254,"eighty":13.922755,"marketCap":11450949559},{"date":"2025-12-24","current":-129.115057,"twenty":-89.343343,"median":-11.58276,"eighty":13.922755,"marketCap":11541830111},{"date":"2026-01-02","current":-129.621563,"twenty":-89.385148,"median":-11.776052,"eighty":13.934648,"marketCap":11632710663},{"date":"2026-01-09","current":-133.340226,"twenty":-90.855167,"median":-22.789601,"eighty":13.934648,"marketCap":11996232871},{"date":"2026-01-16","current":-135.809309,"twenty":-96.214774,"median":-24.4212,"eighty":13.934648,"marketCap":12258074528},{"date":"2026-01-23","current":-134.932765,"twenty":-97.941067,"median":-25.252446,"eighty":13.934648,"marketCap":12167273976},{"date":"2026-01-30","current":-158.375813,"twenty":-100.15633,"median":-25.653279,"eighty":13.934648,"marketCap":14346487225},{"date":"2026-02-06","current":-163.974176,"twenty":-116.245243,"median":-25.653279,"eighty":13.934648,"marketCap":14891290537},{"date":"2026-02-13","current":-162.043578,"twenty":-120.222251,"median":-25.684915,"eighty":13.922755,"marketCap":14800489985},{"date":"2026-02-20","current":-168.250715,"twenty":-121.922853,"median":-25.570127,"eighty":13.94654,"marketCap":15345293298},{"date":"2026-02-27","current":-152.638791,"twenty":-123.147379,"median":-25.570127,"eighty":13.94654,"marketCap":14074085569},{"date":"2026-03-06","current":-145.937152,"twenty":-125.836872,"median":-25.570127,"eighty":13.94654,"marketCap":13347681152},{"date":"2026-03-13","current":-141.315211,"twenty":-128.463999,"median":-25.570127,"eighty":13.94654,"marketCap":12984478944},{"date":"2026-03-20","current":-136.89247,"twenty":-128.88509,"median":-25.570127,"eighty":13.94654,"marketCap":12530476184},{"date":"2026-03-27","current":-135.252627,"twenty":-129.286477,"median":-26.222352,"eighty":13.872469,"marketCap":12348875080},{"date":"2026-04-02","current":62.622294,"twenty":-129.591807,"median":-26.367701,"eighty":13.778938,"marketCap":12802877840},{"date":"2026-04-10","current":62.758937,"twenty":-129.591807,"median":-26.367701,"eighty":13.778938,"marketCap":12929774294},{"date":"2026-04-17","current":58.345701,"twenty":-129.591807,"median":-26.367701,"eighty":13.778938,"marketCap":12025594273},{"date":"2026-04-24","current":57.903729,"twenty":-129.591807,"median":-26.367701,"eighty":13.778938,"marketCap":11935176271},{"date":"2026-04-30","current":55.696119,"twenty":-129.591807,"median":-26.367701,"eighty":13.778938,"marketCap":11483086261},{"date":"2026-05-08","current":53.318298,"twenty":-129.621563,"median":-26.410489,"eighty":13.75323,"marketCap":11030996251},{"date":"2026-05-15","current":47.947764,"twenty":-129.621563,"median":-26.410489,"eighty":13.75323,"marketCap":9945980226},{"date":"2026-05-22","current":45.436272,"twenty":-129.591807,"median":-26.367701,"eighty":13.778938,"marketCap":9403472214},{"date":"2026-05-29","current":41.795837,"twenty":-129.621563,"median":-26.410489,"eighty":13.75323,"marketCap":8680128197},{"date":"2026-06-05","current":40.865781,"twenty":-129.621563,"median":-26.410489,"eighty":13.75323,"marketCap":8499292193},{"date":"2026-06-12","current":40.893441,"twenty":-129.621563,"median":-26.410489,"eighty":13.75323,"marketCap":8499292193},{"date":"2026-06-18","current":37.757596,"twenty":-129.591807,"median":-26.367701,"eighty":13.778938,"marketCap":7866366179},{"date":"2026-06-26","current":36.11832,"twenty":-129.621563,"median":-26.410489,"eighty":13.75323,"marketCap":7488094170},{"date":"2026-07-03","current":38.700332,"twenty":-129.621563,"median":-26.410489,"eighty":13.75323,"marketCap":8029402183},{"date":"2026-07-10","current":37.006407,"twenty":-129.621563,"median":-26.410489,"eighty":13.75323,"marketCap":7668530175},{"date":"2026-07-17","current":37.309002,"twenty":-129.621563,"median":-26.410489,"eighty":13.75323,"marketCap":7758748177},{"date":"2026-07-24","current":38.168077,"twenty":-129.621563,"median":-26.410489,"eighty":13.75323,"marketCap":7939184181},{"date":"2026-07-31","current":38.961518,"twenty":-129.677118,"median":-26.436082,"eighty":13.630989,"marketCap":8119620185},{"date":"2026-08-07","current":39.102047,"twenty":-129.677118,"median":-26.436082,"eighty":13.630989,"marketCap":8164729186},{"date":"2026-08-14","current":37.110765,"twenty":-129.677118,"median":-26.436082,"eighty":13.630989,"marketCap":7758748177},{"date":"2026-08-21","current":37.674785,"twenty":-129.677118,"median":-26.436082,"eighty":13.630989,"marketCap":7894075180},{"date":"2026-08-26","current":35.095601,"twenty":-129.677118,"median":-26.436082,"eighty":13.630989,"marketCap":7352767167}],"updateTime":1787787116042},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"00460\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1129525813","title":"Sihuan Pharmaceutical Returns to Profitability with FY Net Income of 180 Million Yuan","url":"https://stock-news.laohu8.com/highlight/detail?id=1129525813","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1129525813?lang=en_us&edition=fundamental","pubTime":"2026-03-31 12:18","pubTimestamp":1774930711,"startTime":"0","endTime":"0","summary":"Sihuan Pharmaceutical (00460) announced its annual results for the period ended December 31, 2025. Total revenue reached approximately RMB 2.618 billion, representing an increase of about 37.7%...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1600","00460","BK1593","BK1515","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188285155","title":"Sihuan Pharmaceutical 2025 Results: Revenue Climbs 37.7%, Turns Profitable on Medical Aesthetics Surge","url":"https://stock-news.laohu8.com/highlight/detail?id=1188285155","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188285155?lang=en_us&edition=fundamental","pubTime":"2026-03-31 12:04","pubTimestamp":1774929877,"startTime":"0","endTime":"0","summary":"Hong Kong-listed Sihuan Pharmaceutical reported FY2025 revenue of RMB2.62 billion, up 37.7% year-on-year, driven mainly by a near-doubling of medical aesthetics sales to RMB1.49 billion. Gross profit...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00460"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623437405","title":"Sihuan Pharma FY25 revenue climbs 37.7% to RMB 2.6 billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2623437405","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623437405?lang=en_us&edition=fundamental","pubTime":"2026-03-31 12:01","pubTimestamp":1774929698,"startTime":"0","endTime":"0","summary":"Sihuan Pharmaceutical swung to profit of RMB 185 million for 2025, reversing a loss a year earlier.Revenue climbed 37.7% to RMB 2.6 billion, driven primarily by medical aesthetics.Operating profit rose to RMB 607 million, helped by higher medical aesthetics sales, tighter cost control, and improved innovative drug revenue.Board proposed a final cash dividend of RMB 0.96 cents per share; cash and equivalents, wealth management products, pledged deposits, and time deposits totaled RMB 4.4 billion at year-end.Group guided 2026 as the first year of a new three-year plan, targeting deeper domestic penetration and faster overseas expansion in medical aesthetics while accelerating innovative drug commercialization.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investmen","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nNDL6CDSrG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1600","00460","BK1593","BK1515","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623051374","title":"Sihuan Pharma -  FY Profit Attributable RMB179.7 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2623051374","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623051374?lang=en_us&edition=fundamental","pubTime":"2026-03-31 12:01","pubTimestamp":1774929694,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nFWN40I1AP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1191","00460","BK1600","BK1515","BK1593"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623034374","title":"Sihuan Pharma -  Final Cash Dividend of RMB0.96 Cents per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2623034374","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623034374?lang=en_us&edition=fundamental","pubTime":"2026-03-31 12:01","pubTimestamp":1774929662,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nPLXC00322:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1191","BK1600","BK1593","00460","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623315221","title":"Xuanzhu Biopharma FY25 loss narrows 55.9% to RMB 250 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2623315221","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623315221?lang=en_us&edition=fundamental","pubTime":"2026-03-30 17:58","pubTimestamp":1774864687,"startTime":"0","endTime":"0","summary":"Xuanzhu Biopharmaceutical posted a net loss of RMB 250 million, narrowing 55.9%.Operating expenses fell 56.6% to RMB 250 million.Commercial rollout accelerated with two oncology launches in 2025, while cash and cash equivalents climbed to RMB 650 million following the October IPO.For 2026, focus remains on expanding NRDL access, advancing indication expansions and pipeline development, while tightening cost management.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Xuanzhu Biopharmaceutical Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on March 30, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260330:nNDL414TVf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00460","BK1600","BK1515","BK1593","BK1191","02575"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621306116","title":"Sihuan Pharmaceutical unit publishes BRIGHT-2 Phase 3 results for biloxcilib plus fulvestrant in JAMA Oncology","url":"https://stock-news.laohu8.com/highlight/detail?id=2621306116","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621306116?lang=en_us&edition=fundamental","pubTime":"2026-03-24 19:48","pubTimestamp":1774352903,"startTime":"0","endTime":"0","summary":"Sihuan said its majority-owned unit Xuanzhu Biopharma published final Phase 3 BRIGHT-2 results for CDK2/4/6 inhibitor piruoxib in combination with fulvestrant in JAMA Oncology.The company stated the study reported a median progression-free survival of 14.7 months versus 7.3 months, with a 46% reduction in risk of disease progression or death.Sihuan said the treatment achieved an objective response rate of 50.3% versus 16.7% in patients with measurable disease.The company said the drug has received China approvals for use in HR+/HER2- advanced or metastatic breast cancer in combination with fulvestrant, as monotherapy, and in combination with an aromatase inhibitor.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sihuan Pharmaceutical Ho","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260324:nNDL3kmNYg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1593","BK1191","BK1600","00460","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621069888","title":"Xuanzhu Biopharmaceutical reports BRIGHT-2 Phase 3 results for Bireociclib plus fulvestrant in HR+/HER2- breast cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2621069888","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621069888?lang=en_us&edition=fundamental","pubTime":"2026-03-24 19:06","pubTimestamp":1774350387,"startTime":"0","endTime":"0","summary":"Xuanzhu reported final Phase 3 BRIGHT-2 results for its breast cancer product bireociclib in combination with fulvestrant, with the analysis published in JAMA Oncology.The company said median progression-free survival was 14.7 months versus 7.3 months for placebo plus fulvestrant, with a 46% reduction in risk of progression or death .In patients with measurable disease, the objective response rate was 50.3% versus 16.7% for the control group.Xuanzhu said bireociclib has been approved in China for use with fulvestrant in HR+/HER2- advanced or metastatic breast cancer after progression on prior endocrine therapy, positioning it for broader clinical adoption.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Xuanzhu Biopharmaceutical Co. Ltd","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260324:nNDL20tgp6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1600","BK1515","BK1593","02575","00460","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621714840","title":"Xuanzhu Biopharmaceutical completes enrollment of 500 patients in China Phase 3 trial of anaprazole sodium enteric-coated tablets for reflux esophagitis","url":"https://stock-news.laohu8.com/highlight/detail?id=2621714840","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621714840?lang=en_us&edition=fundamental","pubTime":"2026-03-22 18:08","pubTimestamp":1774174088,"startTime":"0","endTime":"0","summary":"Xuanzhu Biopharmaceutical completes enrollment of 500 patients in China Phase 3 trial of anaprazole sodium enteric-coated tablets for reflux esophagitis. Xuanzhu reported full enrollment of 500 adults in a China Phase 3 trial of its product Anaprazole Sodium enteric-coated tablets  for reflux esophagitis.The trial milestone positions the program for potential expansion beyond Anaprazole’s existing China approval for duodenal ulcer treatment.Completion of enrollment may support near-term differentiation in the domestic reflux esophagitis market by advancing a locally developed therapy through late-stage development.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Xuanzhu Biopharmaceutical Co. Ltd. published the original content used to g","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260322:nNDL6JMbm8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00460","BK1191","02575","BK1600","BK1515","BK1593"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621714823","title":"Xuanzhu Biopharmaceutical completes enrollment of 500 subjects in China Phase III reflux esophagitis trial of anaprazole sodium tablets","url":"https://stock-news.laohu8.com/highlight/detail?id=2621714823","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621714823?lang=en_us&edition=fundamental","pubTime":"2026-03-22 18:08","pubTimestamp":1774174083,"startTime":"0","endTime":"0","summary":"Xuanzhu Biopharmaceutical completes enrollment of 500 subjects in China Phase III reflux esophagitis trial of anaprazole sodium tablets. Xuanzhu Biopharma reported completion of enrollment of 500 subjects in a China Phase III trial of anaprazole sodium enteric-coated tablets  for adult reflux esophagitis.The pivotal study is multi-center, randomized, double-blind, double-dummy, and active-controlled.The primary endpoint is endoscopic healing rate within 8 weeks of treatment.Secondary endpoints include endoscopic healing rate at week 4 and symptom changes at week 4 and week 8.No trial results were reported in the announcement.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Xuanzhu Biopharmaceutical Co. Ltd. published the original conten","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260322:nNDL8162Qw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","BK1593","BK1600","00460","BK1191","02575"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161078965","title":"Sihuan Pharma (00460) Schedules 31 Mar 2026 Board Meeting to Approve FY2025 Results and Consider Final Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=1161078965","media":"Bulletin Express","labels":["conferences","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1161078965?lang=en_us&edition=fundamental","pubTime":"2026-03-19 16:43","pubTimestamp":1773909795,"startTime":"0","endTime":"0","summary":"Sihuan Pharmaceutical Holdings Group Ltd. (stock code: 00460) has announced that its board of directors will convene on 31 March 2026. Key agenda items include: • Approval and publication of the...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00460"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618793945","title":"Assessing Sihuan Pharmaceutical Holdings Group’s Valuation After Bireociclib’s New First Line Breast Cancer Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2618793945","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618793945?lang=en_us&edition=fundamental","pubTime":"2026-03-11 16:39","pubTimestamp":1773218361,"startTime":"0","endTime":"0","summary":"Sihuan Pharmaceutical Holdings Group (SEHK:460) drew investor attention after China approved a new first-line indication for its Bireociclib Tablets in HR+/HER2- advanced breast cancer, expanding coverage across all treatment lines.\nSee our latest analysis for Sihuan Pharmaceutical Holdings Group.\nAt a share price of HK$1.49, the stock has seen a 6.43% 7 day share price return and a 16.41% 90 day share price return. The 1 year total shareholder return of 150.06% points to strong momentum,...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-460/sihuan-pharmaceutical-holdings-group-shares/news/assessing-sihuan-pharmaceutical-holdings-groups-valuation-af","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-460/sihuan-pharmaceutical-holdings-group-shares/news/assessing-sihuan-pharmaceutical-holdings-groups-valuation-af","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1593","BK1600","00460","BK1515","BK1191","DCF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617664402","title":"Sihuan Pharmaceutical affiliate Xuanzhu Biopharm enters Hong Kong Stock Connect list","url":"https://stock-news.laohu8.com/highlight/detail?id=2617664402","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617664402?lang=en_us&edition=fundamental","pubTime":"2026-03-08 18:13","pubTimestamp":1772964828,"startTime":"0","endTime":"0","summary":"Sihuan Pharmaceutical Holdings Group Ltd. said its non-wholly-owned subsidiary, Xuanzhu Biopharmaceutical Co., Ltd., has been added to the list of eligible stocks in Hong Kong Stock Connect under both the Shanghai-Hong Kong and Shenzhen-Hong Kong programs, effective March 9, 2026. The company said the inclusion is expected to broaden Xuanzhu Biopharm’s shareholder base and improve share liquidity, benefiting the group through potential revaluation and stronger market performance.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sihuan Pharmaceutical Holdings Group Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on March 08, 2026, and ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260308:nNDL4H8KhX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00460","BK1600","BK1515","BK1593","BK1191","02575"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126363613","title":"SIHUAN PHARM (00460) Rises Over 5% in Morning Session as Xuan Yue Ning® Gains Third Indication Approval from NMPA","url":"https://stock-news.laohu8.com/highlight/detail?id=1126363613","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1126363613?lang=en_us&edition=fundamental","pubTime":"2026-03-05 11:36","pubTimestamp":1772681786,"startTime":"0","endTime":"0","summary":"SIHUAN PHARM (00460) saw an increase of more than 5% before the midday break. As of the time of writing, the stock had risen by 5.19% to HK$1.42, with a turnover of HK$19.4691 million. On March 3,...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK1600","VT","BK1593","BK1515","BK4585","00460","BK1191","VXUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616346818","title":"BRIEF-Sihuan Pharma Reports Marketing Approval For Bireociclib Tablets Granted By NMPA","url":"https://stock-news.laohu8.com/highlight/detail?id=2616346818","media":"Reuters","labels":["productRelease","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616346818?lang=en_us&edition=fundamental","pubTime":"2026-03-03 18:25","pubTimestamp":1772533550,"startTime":"0","endTime":"0","summary":"BRIEF-Sihuan Pharma Reports Marketing Approval For Bireociclib Tablets Granted By NMPAMarch 3 (Reuters) - Sihuan Pharmaceutical 0460.HK:MARKETING APPROVAL FOR BIREOCICLIB TABLETS GRANTED BY NMPAFurther company coverage: 0460.HK ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260303:nFWN3ZQ1JJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","BK1593","BK1191","00460","BK1600"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1105924238","title":"Sihuan Pharmaceutical (0460) Gains NMPA Approval for Third Indication of Bireociclib in First-Line HR+/HER2- Advanced Breast Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=1105924238","media":"Bulletin Express","labels":["productRelease","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1105924238?lang=en_us&edition=fundamental","pubTime":"2026-03-03 17:07","pubTimestamp":1772528876,"startTime":"0","endTime":"0","summary":"Sihuan Pharmaceutical Holdings Group Ltd. (0460) announced that the National Medical Products Administration of China granted marketing approval for the third indication of its innovative drug...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00460"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616173103","title":"Sihuan Pharma - Marketing Approval for Bireociclib Tablets Granted by Nmpa","url":"https://stock-news.laohu8.com/highlight/detail?id=2616173103","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616173103?lang=en_us&edition=fundamental","pubTime":"2026-03-03 16:44","pubTimestamp":1772527442,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260303:nFWN3ZQ1JJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1593","BK1515","BK1191","00460","BK1600"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616127853","title":"China NMPA grants Xuanzhu Biopharmaceutical approval for Xuanyuening in first-line HR+/HER2- advanced breast cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2616127853","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616127853?lang=en_us&edition=fundamental","pubTime":"2026-03-03 16:39","pubTimestamp":1772527147,"startTime":"0","endTime":"0","summary":"Xuanzhu Biopharmaceutical Co. Ltd. said China’s National Medical Products Administration  has granted marketing approval for a new indication of its Bireociclib tablets  in combination with an aromatase inhibitor for first-line treatment of HR+/HER2- advanced breast cancer. The company said this is Bireociclib’s third approved indication in China, following approvals for use with fulvestrant and as a monotherapy.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Xuanzhu Biopharmaceutical Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on March 03, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260303:nNDL9hzLjt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1600","00460","BK1593","02575","BK1515","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150892152","title":"Sihuan Pharmaceutical (00460) Publishes February 2026 Monthly Return, Confirms Public Float Compliance","url":"https://stock-news.laohu8.com/highlight/detail?id=1150892152","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150892152?lang=en_us&edition=fundamental","pubTime":"2026-03-02 16:23","pubTimestamp":1772439810,"startTime":"0","endTime":"0","summary":"Sihuan Pharmaceutical Holdings Group Ltd. (00460) has released its monthly return covering the period ended 28 February 2026. According to the report, the authorized share capital remains at 1.00...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00460"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":6,"totalSize":119,"code":"91000000","status":"200"}]}}